Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study

Table 1 Baseline patient characteristics

Subjects treated	50
Most frequent age range	41–45 years^a
Mean menstrual pictogram (MP) score	423 ± 253 (range, 119–1582)
Mean UFS-QOL SSS score	61.7 ± 16.9 (range, 28.1–100.0)
Mean UFS-QOL HRQOL score	34.3 ± 19.0 (range, 0.0–73.3)
Total number of target fibroids identified on MRI	118
Mean number of target fibroids per patient	2.4 ± 1.7 (range, 1–7)^b
Mean diameter of target fibroids	2.9 ± 1.4 cm (range, 1.0–6.9 cm)
Mean perfused fibroid volume	18.3 ± 20.6 cc (range, 0.3–77.0 cc)
Mean total (perfused + nonperfused) fibroid volume	18.8 ± 21.4 cc (range, 0.3–77.0 cc)

^aSubject ages were specified as a range by each site to protect subject privacy
^bTwo small additional fibroids, beyond the upper limit of five target fibroids/patient, were identified on review of one MRI series after treatment